6 However, subgroup analyses from some trials showed a trend toward benefit in patients with triglycerides ≥200 mg/dL (≥2.3 mmol/L) and HDL-C ≤ 40 mg/dL (≤1.0 mmol/L) who received fibrates. 82 – 85 Patients with severely elevated triglycerides (>500 mg/dL [>5.7 mmol/L]) are at risk of pancreatitis.
← all excerpts
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
1
—
—